Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Levonorgestrel and Ethinyl Estradiol 0.1 mg/0.02 mg
NCT04194905Phase 1Completed
- Sponsor
- Laboratorios Andromaco S.A.
- Start
- Nov 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of avatrombopag and ethinyl estradiol in contraception (2 arms), sponsored by Laboratorios Andromaco S.A. Primary endpoints: Area Under the Plasma Concentration-Time Curve From 0 to 72 Hours, Area Under the Plasma Concentration-Time Curve From 0 to Time t at 72 hours and 1 more. Started Nov 2020; status: completed.
02
Drugs
avatrombopagethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT04194905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04194905.